Recent apparent changes to 340B drug pricing conditions by drug manufacturer Sanofi may eliminate 340B discounts for health centers using [...] …
Category: Pharma Industry
The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...] …
The Department of Health and Human Services (HHS) today announced the first 10 prescription drugs eligible for Medicare price negotiations [...] …
Drugmaker AstraZeneca sued the federal government to block Medicare drug price negotiations on Friday, just days before the government announced [...] …
A health center challenging the government’s 340B program patient definition in a federal district court recently asked a federal judge [...] …
An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...] …
The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...] …
Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...] …
The proportion of retail contract pharmacies in the 340B program that contract exclusively with “core safety-net” facilities fell from 95% [...] …
The U.S. Department of Health and Human Services (HHS) asked a federal court to deny a preliminary injunction sought by [...] …